You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma

Article metrics

Article menu

Download PDFPDF

XML
Immunotherapy biomarkers
Original research
Characterization of tumor mutation burden, PD-L1 and DNA repair genes to assess relationship to immune checkpoint inhibitors response in metastatic renal cell carcinoma

 

Online download statistics by month:

Online download statistics by month: March 2020 to September 2025

AbstractFullPdf
Mar 202022822895
Apr 2020624624216
May 2020442442114
Jun 202042442482
Jul 202044044070
Aug 202037337137
Sep 202028028044
Oct 202021121144
Nov 202016516543
Dec 202019719756
Jan 202115515545
Feb 202116616644
Mar 202120520531
Apr 202110810826
May 2021828249
Jun 202110310429
Jul 2021868649
Aug 2021515135
Sep 2021646441
Oct 202111811869
Nov 2021616140
Dec 2021646850
Jan 2022546241
Feb 2022424732
Mar 2022626426
Apr 2022667129
May 2022717542
Jun 2022636723
Jul 2022454629
Aug 2022384034
Sep 2022424222
Oct 2022585941
Nov 2022697134
Dec 2022414118
Jan 2023666820
Feb 2023989821
Mar 2023767824
Apr 2023606030
May 2023555721
Jun 2023777834
Jul 2023656525
Aug 2023828416
Sep 2023747623
Oct 2023676715
Nov 2023797914
Dec 2023293012
Jan 2024293029
Feb 2024404220
Mar 2024585882
Apr 2024687034
May 2024424216
Jun 2024383816
Jul 202450519
Aug 2024576021
Sep 2024414120
Oct 2024636326
Nov 2024585922
Dec 2024394017
Jan 2025616121
Feb 202512812815
Mar 2025494921
Apr 202511011028
May 2025737417
Jun 2025303015
Sep 2025111
Total716172222365